Full recording now available on-demand!
On August 26, 2020, IPA hosted this complimentary live webinar sponsored by Neopharm Labs.
Presentation Outline:
- What are Nitrosamine impurities?
- The Valsartan Issue
- FDA Recall History
- Current Regulatory Situation
- Analytical Strategies and Options
- Case Studies
Presented by: Mathieu Fournier, Director, R&D and Scientific Affairs, Neopharm Labs.
If you missed out the live presentation, don’t worry! You can now access the on-demand webinar online. Click here to obtain access.